4/A: Centene CEO Amends Holdings, Forfeits Unvested PSUs

Centene CEO Sarah London amended her beneficial ownership report, reflecting the forfeiture of 141,103 unvested performance stock units and the acquisition of new equity awards.

Summary

• An amendment to the Form 4 filed on January 28, 2026, was submitted by Centene Corp's CEO, Sarah London.
• The amendment's primary purpose is to remove 141,103 unvested performance stock units (PSUs) from the total holdings amount.
• These PSUs for the performance period ending December 31, 2025, did not meet the vesting criteria as determined by the Compensation and Talent Committee on January 26, 2026.
• On January 26, 2026, Sarah London acquired 520,720 shares of common stock at a price of $0.
• This new award includes 138,859 restricted stock units (RSUs) that will vest in three annual installments beginning March 15, 2027.
• It also includes 69,429 RSUs that will vest in five annual installments beginning March 15, 2027.
• Additionally, the award comprises 312,432 performance stock units (PSUs) reported at target level performance.
• The actual number of these new PSUs that will vest on March 15, 2029, ranges from 0% to 200% of the reported target, based on the company's stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028.
• Following these reported transactions, Sarah London's total beneficial ownership stands at 1,224,892 shares.
• This total includes 450,895 shares of previously-granted restricted stock units and performance stock units (reported at target level performance) that are still subject to vesting requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a mixed filing. While new equity awards align management with long-term performance, the forfeiture of a substantial number of PSUs indicates a failure to meet prior performance targets.

Positives

• CEO Sarah London received a new equity award of 520,720 shares, demonstrating continued alignment with shareholder interests through long-term incentives.
• The new award includes a significant portion of performance stock units (312,432 at target), directly linking future executive compensation to the company's stock price performance over several years.

Negatives

• 141,103 performance stock units for the period ending December 31, 2025, did not meet vesting criteria and were forfeited, indicating that specific performance targets were not achieved.

Risks

• The future vesting of 312,432 performance stock units is contingent on the company's stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028, introducing market-based risk to executive compensation.

Future Outlook

The vesting of a significant portion of the CEO's new equity award (312,432 performance stock units) is tied to the company's stock price performance through the end of 2028, indicating a long-term incentive structure focused on market value appreciation.

Management Comments

• The Compensation and Talent Committee on January 26, 2026, determined that performance stock units for the performance period ending on December 31, 2025, did not meet the vesting criteria.

Industry Context

StockSavvy.ai notes that executive compensation structures, particularly those involving performance-based equity, are common across the healthcare and managed care industry. The forfeiture of PSUs due to unmet targets highlights the increasing scrutiny on linking executive pay to tangible performance outcomes, a trend observed broadly in corporate governance.

Comparison to Industry Standards

• The structure of linking a significant portion of executive compensation to stock price performance over a multi-year period (e.g., 2025-2028 for PSUs) is consistent with best practices in executive incentive plans across large-cap companies, including peers like UnitedHealth Group (UNH) and Anthem (now Elevance Health, ELV), which also utilize long-term incentive plans tied to shareholder value creation.
• The forfeiture of 141,103 PSUs due to unmet vesting criteria demonstrates a robust performance-based compensation system, aligning with investor expectations for accountability, similar to how companies like CVS Health (CVS) or Humana (HUM) structure their executive incentives to ensure targets are met.

Corporate Governance

Stakeholder Impact

• Shareholders: The forfeiture of unvested PSUs demonstrates accountability in executive compensation, which may be viewed positively. The new performance-based awards align the CEO's incentives with long-term shareholder value creation.
• Management/CEO: Direct impact on compensation due to the forfeiture of prior PSUs and the receipt of new awards with future vesting conditions tied to company performance.

Next Steps

• Vesting of 138,859 restricted stock units in three annual installments beginning March 15, 2027.
• Vesting of 69,429 restricted stock units in five annual installments beginning March 15, 2027.
• Vesting of 312,432 performance stock units (at target) on March 15, 2029, contingent on stock price performance.

Key Dates

Recommendation

The filing presents a mixed signal. While the forfeiture of performance stock units indicates a failure to meet past targets, which is a negative, the new equity awards, particularly the performance-based units, align the CEO's incentives with future stock price appreciation. This suggests a commitment to long-term value creation, but the past underperformance prevents a more bullish outlook. Therefore, a "hold" recommendation is appropriate as investors await further clarity on future performance.

Keywords

Centene, CNC, Sarah London, SEC Form 4, beneficial ownership, restricted stock units, performance stock units, executive compensation, equity awards, stock vesting